(Q53506544)

15 May 2018

title

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients. (English)

1 reference

15 May 2018

1 reference

1

1 reference

15 May 2018

Sokbom Kang

2

1 reference

15 May 2018

author name string

Sang-Soo Seo

3

1 reference

15 May 2018

Sun-Young Kong

4

1 reference

15 May 2018

Bo-Yon Lee

5

1 reference

15 May 2018

Seon-Kyung Lee

6

1 reference

15 May 2018

Sang-Yoon Park

7

1 reference

15 May 2018

publication date

5 June 2009

1 reference

15 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

15 May 2018

volume

135

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

page(s)

1593-1599

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-009-0607-3

exact match

0 references

cites work

Risk factors for ovarian cancer: a case-control study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0607-3

The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0607-3

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing

21 January 2018

1 reference

12 December 2020

Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic

1 reference

12 December 2020

High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families

1 reference

12 December 2020

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

1 reference

12 December 2020

Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan

1 reference

12 December 2020

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

1 reference

12 December 2020

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

12 December 2020

BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients

1 reference

12 December 2020

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

1 reference

12 December 2020

Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations

1 reference

12 December 2020

Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients

1 reference

12 December 2020

Hereditary ovarian cancer in Poland.

1 reference

12 December 2020

Hereditary ovarian cancer

1 reference

12 December 2020

Ovarian cancer incidence and survival in Korea: 1993-2002

1 reference

12 December 2020

Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations

1 reference

12 December 2020

Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

1 reference

12 December 2020

BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations

1 reference

12 December 2020

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

1 reference

12 December 2020

Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma.

1 reference

12 December 2020

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

1 reference

12 December 2020

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

1 reference

12 December 2020

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

12 December 2020

Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients

1 reference

12 December 2020

BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer

1 reference

12 December 2020

Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.

1 reference

12 December 2020

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

1 reference

12 December 2020

Genomic rearrangements in the BRCA1 and BRCA2 genes.

1 reference

12 December 2020

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes

1 reference

12 December 2020

Population genetics of BRCA1 and BRCA2.

1 reference

12 December 2020

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

1 reference

12 December 2020

10.1007/S00432-009-0607-3

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018